AFT Pharmaceuticals Ltd
NZX:AFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
NZ |
|
W
|
Wolters Kluwer NV
DUS:WOSB
|
NL |
|
D
|
Desert Control AS
OSE:DSRT
|
NO |
|
E
|
Endeavour Silver Corp
LSE:0R2C
|
CA |
|
T
|
Trident Ltd
BSE:521064
|
IN |
|
F
|
Freeport-McMoRan Inc
F:FPMB
|
US |
|
V
|
Valeo SE
F:VSA
|
FR |
|
A
|
American International Group Inc
DUS:AINN
|
US |
|
D
|
DRDGOLD Ltd
XMUN:DUB1
|
ZA |
|
Scentre Group
ASX:SCG
|
AU |
|
U
|
UniCredit SpA
LSE:0RLS
|
IT |
|
ING Groep NV
AEX:INGA
|
NL |
Dividends
Dividend Yield
AFT Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
AFT Pharmaceuticals Ltd
Payout Ratio
AFT Pharmaceuticals Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for AFT is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AFT Price
AFT Pharmaceuticals Ltd
| Average Annual Return | -10.41% |
| Standard Deviation of Annual Returns | 8.79% |
| Max Drawdown | -52% |
| Market Capitalization | 382.8m NZD |
| Shares Outstanding | 104 870 000 |
| Percentage of Shares Shorted |
N/A
|
